Pemetrexed Disodium Injection
Brand names: Alimta, Pemetrexed
Category: Oncology
FDA status: To Be Discontinued · Last FDA update: Oct 16, 2025 · First posted: Oct 10, 2025 · 2 manufacturers, 4 listed presentations
As of Oct 16, 2025, the FDA lists Pemetrexed Disodium Injection as being discontinued. Of 4 manufacturer presentations, 4 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01) NDC 0002-7640-01 |
Eli Lilly and Co. | Not specified | Discontinuation of the manufacture of the drug |
| Pemetrexed Disodium, Injection, 100 mg/4 mL (NDC 0781-3518-76) NDC 0781-3518-76 |
Sandoz Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Alimta, Injection, 500 mg/20 mL (NDC 0002-7623-01) NDC 0002-7623-01 |
Eli Lilly and Co. | Not specified | Discontinuation of the manufacture of the drug |
| Pemetrexed Disodium, Injection, 500 mg/20 mL (NDC 0781-3519-90) NDC 0781-3519-90 |
Sandoz Inc. | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Pemetrexed Disodium Injection (FDA data as of Oct 16, 2025). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Pemetrexed Disodium Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/pemetrexed-disodium-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).